Zeto Secures $31 Million in Series B Funding for EEG Innovation
Zeto, Inc., a rapidly growing medical technology company, has successfully secured $31 million in Series B funding. This significant investment was led by MindWorks Global (MWG), a Michigan-based investment entity known for its track record of building multi-billion-dollar enterprises. The funding will enable Zeto to expand its commercial and operational teams, drive further growth, and strengthen ongoing research and development efforts.
Zeto is at the forefront of advancing EEG brain monitoring and diagnostics in healthcare. The company’s innovative wearable devices and AI-driven cloud platform make brain monitoring accessible in diverse clinical settings, including the ICU, ED, hospitals, offices, and at home. Backed by a powerful cloud-based platform, Zeto delivers nationwide monitoring and interpretation services by neurologists, along with AI-driven notifications for conditions such as seizures and epilepsy.
The company’s EEG systems, which received FDA clearances in 2018 and 2024, are currently commercially available in the United States. Zeto’s vision and technology are seen as transformative for the medical arena and beyond, with the potential to extend brain health assessment beyond traditional healthcare.
Mike Williams, Founder, CEO, and Lead Partner of MindWorks Global, expressed his enthusiasm for Zeto’s future, stating, “Zeto’s vision and technology are truly transformative for the medical arena and beyond, and we are excited to leverage our expertise and network to help drive the company’s growth. The world of EEG is going to be transformed immensely in the upcoming years, and Zeto is going to be at the forefront of it.”
Aswin Gunasekar, Zeto’s Founder and CEO, highlighted the significance of this funding milestone, saying, “Zeto has reached a pivotal milestone, earning a reputation for game-changing innovation and experiencing rapid adoption of our solutions by leading healthcare institutions across the U.S. Our management team has long aspired to collaborate with accomplished entrepreneur-investors who have successfully scaled companies to drive meaningful societal impact and significant revenue.”
Zeto’s dedicated team is eager to embark on this exciting next chapter in the company’s journey. The new funding will enable Zeto to expand its capabilities to detect and manage conditions like depression, stroke, and traumatic brain injury. The company is grateful for the steadfast support and continued investments from its prior investors over the years.
Zeto’s innovative approach to EEG diagnostics has been recognized for its potential to revolutionize the field. The company’s Instant EEG Platform (zEEG) provides a zero-prep, wireless, dry electrode headset that can be used to perform routine or urgent EEGs anywhere without the need for a technician. Data is immediately streamed to a secure cloud platform that provides live display, tools for analysis, and optional remote interpretation by neurologists.
This funding marks a significant step forward for Zeto, positioning the company to lead the transformation of EEG diagnostics and expand its impact on healthcare. With the support of MindWorks Global and its network, Zeto is poised to pioneer new frontiers in brain health assessment and diagnostics.
See more funded startups in USA.